Digital Pathology Market Size to Surpass USD 6.55 Billion by 2035, Rising at a CAGR of 17.15% | Report by Vantage Market Research
NEW YORK, Oct. 29, 2025 The Global Digital Pathology Market is projected to grow from USD 1.15 billion in 2024 to...
Clinical Trial
BioLab Holdings Inc. Announces Multiple Clinical Trials to Advance Chronic Wound Care
The unique amniotic membrane allografts aid in the covering and protection of wounds PHOENIX, Oct. 29, 2025 /PRNewswire/ -- BioLab...
Microbiome Labs Expands Portfolio with Launch of Women’s Health Line
Franklinton, North Carolina--(Newsfile Corp. - October 29, 2025) - Microbiome Labs, a leader in microbiome-based solutions, today announced the launch...
Lilly announces more than $1.2 billion investment in Puerto Rico facility to boost oral medicine manufacturing capacity in the United States
Company plans to create 100 manufacturing jobs and up to 1,000 construction jobs INDIANAPOLIS, Oct. 29, 2025 /PRNewswire/ -- Eli...
Clinical Analytics Market worth $81.32 billion by 2030 with 19.7% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., Oct. 29, 2025 /PRNewswire/ -- The global Clinical Analytics Market, valued at US$27.65 billion in 2024, stood...
Suvoda launches unified patient app to reduce logistical challenges for clinical trial participants
CONSHOHOCKEN, Pa., Oct. 29, 2025 /PRNewswire/ -- Suvoda (recently merged under common ownership with Greenphire), a global clinical trial technology company...
Treating Measles Infection: Nanoviricides CEO Dr Anil Diwan Interviewed by Steve Darling from Proactive
SHELTON, CONNECTICUT / ACCESS Newswire / October 29, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"),...
Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for Skinject(TM) in Patients with Gorlin Syndrome
Gorlin Syndrome, also known as Nevoid Basal Cell Carcinoma Syndrome, is a rare inherited genetic disorder affecting 1 in 31,000...
Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.2 Million Gross Proceeds
PHOENIX, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc., (Nasdaq: CELZ) (the “Company”), a clinical-stage biotechnology company...
I-MAB (Nasdaq: IMAB) Transitions to NovaBridge Biosciences (Nasdaq: NBP) with Trading Effective October 30, 2025 New Brand and Logo to Reflect Strategic Transformation to a Global Biotech Platform
New corporate brand reflects strategic transformation to a global biotech platform accelerating access to innovative medicines for patients worldwideStrategy centers...
PDS Biotech to Seek Expedited Approval Pathway for PDS0101 in HPV16-Positive Head and Neck Cancer
Company aims to shorten time frame to make PDS0101 available to patients with HPV16-positive head and neck cancer, projected to...
Moleculin Expands Global IP Portfolio with New Australian Patent for Annamycin
HOUSTON, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company...
Hemogenyx Pharmaceuticals PLC Announces Clinical Trial Update and Grant of Share Awards
DSMB Clearance to Proceed to the Next Dose Level of HG-CT-1 in Adult Patients, Opening Pediatric Recruitment, and Grant of...
Lilly partners with NVIDIA to build the industry’s most powerful AI supercomputer, supercharging medicine discovery and delivery for patients
New AI capabilities will help scientists identify, optimize and validate new molecules Additional applications include manufacturing, medical imaging and enterprise...
Hemostemix Announces Its Webinar for Florida Vascular Surgeons: Autologous Stem Cell Therapy for CLTI
Calgary, Alberta--(Newsfile Corp. - October 28, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's...
NORD Unveils IAMRARE Mobile App Companion to IAMRARE Registry Platform
On-the-go app helps patients and caregivers share health information to support rare disease research DANBURY, Conn., Oct. 28, 2025 /PRNewswire/...
ObvioHealth and Vaxxas Sign Multi-Year Agreement to Power Needle-Free Vaccination Technology Trials with ObvioGo®
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- ObvioHealth, a global leader in digital clinical trial solutions, announced that it has signed...
Luminopia Collaborates with Crunchyroll to Continue Building Its Extensive Content Library for Pediatric Lazy Eye Patients
Kids using Luminopia can now watch popular anime shows, further diversifying their content selection CAMBRIDGE, Mass., Oct. 28, 2025...
ALTIUS AND SYD LIFE AI ANNOUNCE $1BN PARTNERSHIP TO TRANSFORM U.S. HEALTHCARE AND WORKFORCE THROUGH PREVENTIVE ARTIFICIAL INTELLIGENCE
Exclusive partnership brings to the U.S. personalized AI preventive care platform, validated in clinical trials by the UK's NHS, to save employers billions of dollars and improve millions of lives LOUISVILLE, Ky....
Where Will Your CGT Study Go? Solving the Site Capacity Challenge, Upcoming Webinar Hosted by Xtalks
In this free webinar, gain insights into identifying and evaluating emerging sites, including how sponsors can build trust in those...